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Abstract
The aim of this study was to obtain saccharide (dextran and sucrose)-coated maghemite nanoparticles with
antibacterial activity. The polysaccharide-coated maghemite nanoparticles were synthesized by an adapted
coprecipitation method. X-ray diffraction (XRD) studies demonstrate that the obtained polysaccharide-coated
maghemite nanoparticles can be indexed into the spinel cubic lattice with a lattice parameter of 8.35 Å. The
refinement of XRD spectra indicated that no other phases except the maghemite are detectable. The
characterization of the polysaccharide-coated maghemite nanoparticles by various techniques is described. The
antibacterial activity of these polysaccharide-coated maghemite nanoparticles (NPs) was tested against
Pseudomonas aeruginosa 1397, Enterococcus faecalis ATCC 29212, Candida krusei 963, and Escherichia coli ATCC
25922 and was found to be dependent on the polysaccharide type. The antibacterial activity of dextran-coated
maghemite was significantly higher than that of sucrose-coated maghemite. The antibacterial studies showed the
potential of dextran-coated iron oxide NPs to be used in a wide range of medical infections.
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Background
The progress in the field of nanoscale science and engin-
eering provides us with unprecedented understanding
and control of matter at atomic and molecular levels.
The recent advances in nanotechnology allow us to fab-
ricate more and more advanced materials with unusual
magnetic, electric, optical, and biological properties [1].
Nanotechnology develops new research on nanostruc-
tured materials [2] in order to answer the yet unsolved
problems in various areas such as environment, medi-
cine, biology, chemistry, and electronics [3-5]. In the
field of biomedical application, outstanding progresses
involving magnetic nanoparticles have been made due to
their unique properties at nanometric scale [6,7]. Nano-
particles have physicochemical properties that are char-
acteristic of neither the atom nor the bulk counterpart
[8]. The size of these nanoparticles makes them ideal for
nanoengineered surfaces and for the production of
functional nanostructures. Those abilities make them
suitable for use in biomedical applications such as con-
trast agents in MRI [9], targeted drug delivery in tumor
therapy, hyperthermia, catalysis, biological separation,
biosensors, and diagnostic medical devices [10,11].
The iron oxide magnetite (Fe3O4) and its oxidized
form maghemite (γ-Fe2O3) are the most studied mag-
netic particles in medicine and biotechnology because of
their unique magnetic properties and biocompatibility at
nanometric scale [12,13]. The important properties of
magnetic particles for biological and biomedical applica-
tions are controllable shape (for biological and bio-
medical purposes, they must have spherical shape),
biocompatibility, nontoxicity, narrow and moderate size
distribution, high crystallinity, large surface areas (for
maximal protein or enzyme binding), and the ability to
well disperse in an aqueous medium [14-17]. In order
to meet these high demands, in the recent years, in-
tense studies involving the means to develop a stable,
nontoxic, and cheap way to obtain magnetic nano-
particles with the abovementioned parameters [18] have
been made. Besides those demands, nowadays, studies
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revealed the need for these particles to exhibit antibac-
terial properties in order to be successfully used in envir-
onmental and biomedical applications [19].
Nowadays, antibiotic resistance has become a serious
public health problem. As a result of the resistance to
the existing portfolio of antimicrobial drugs, there is an
increasing need to design new antibacterial and antifun-
gal agents with better activity profiles and lower toxicity
[20]. Nanotechnology is expected to open some new
ways to fight and prevent diseases using atomic scale-
tailored materials [21]. Bio-nanotechnology investigates
the interactions between nanoscale materials and bio-
logical systems and creates the technologies for inter-
facing the two. The insertion of prosthetic medical
devices for different exploratory or therapeutical pur-
poses, especially in severe pathological conditions, repre-
sents a risk factor for the occurrence of chronic
infections in developed countries, being characterized by
slow onset, middle-intensity symptoms, chronic evolu-
tion, and resistance to antibiotic treatment [22]. The mi-
crobial species of clinical interest, often involved in
biofilm-associated diseases, belong to a very large
spectrum, from the Gram-positive (Staphylococcus epi-
dermidis and Staphylococcus aureus) to the Gram-
negative (Pseudomonas aeruginosa and Escherichia coli)
pathogens and to the different members of the genus
Candida [23]. Iron oxide-based magnetic nanoparticles
have been widely used in a variety of biomedical
applications such as magnetic separation, magnetic
resonance imaging, hyperthermia, magnetically guided
drug delivery, tissue repair, and molecular diagnostics
[24].
The aim of this article is to integrate and extend infor-
mation from journal literature about antibacterial prop-
erties of iron oxide coated with different saccharides. In
this work, polysaccharide-coated iron oxide nanoparti-
cles were synthesized by an adapted coprecipitation
method. The obtained polysaccharide-coated maghemite
nanoparticles were systematically investigated by X-ray
diffraction and transmission electron microscopy (TEM).
The magnetic hysteresis cycles for the powder samples
were also determined at room temperature. The antibac-
terial activity of these polysaccharide-coated maghemite
nanoparticles (PMC-NPs) was tested against P. aeruginosa
1397, Enterococcus faecalis ATCC 29212, Candida krusei
963, and E. coli ATCC 25922.
Methods
Materials
Dextran (H(C6H10O5)xOH; MW ~ 40,000) and sucrose
(C12H22O11) were purchased from Merck (Whitehouse
Station, NJ, USA). Iron dichloride tetrahydrate
(FeCl2·4H2O), iron trichloride hexahydrate (FeCl3·6H2O),
sodium hydroxide (NaOH), potassium dichromate
(K2Cr2O7), hydrochloric acid (HCl), and perchloric acid
(HClO4) were also purchased from Merck. Deionized
water was used in the synthesis of nanoparticles.
Synthesis of dextran-coated iron oxide
Iron dichloride tetrahydrate (FeCl2·4H2O) in 2 M HCl
and iron trichloride hexahydrate (FeCl3·6H2O) were
mixed at 90°C (Fe2+/Fe3+ = ½). The mixture was
dropped into dextran (20 g in 100 mL of water) and 200
mL of NaOH (2 mol·L−1) solution under vigorous stir-
ring for about 30 min. The resulting solution was heated
at 90°C for 1 h with continuous agitation (200 rotations/
min). The 5 M NaOH was added dropwise to obtain a
pH of 11. The precipitate was centrifuged and treated
repeatedly with perchloric acid (3 mol·L−1) solution until
the Fe2+/Fe3+ ratio in the solid was approximately 0.05.
After the last separation by centrifugation, the particles
were dispersed into dextran (20 g in 100 mL of water).
The product was dried at 40°C (dextran-coated iron
oxide (DIO)-NP samples).
Synthesis of sucrose-coated iron oxide
The sucrose solution (20 g in 100 mL of water) was
heated at 90°C for 1 h with continuous agitation (200
rotations/min), and 200 mL of NaOH (2 mol·L−1) solu-
tion was added slowly. FeCl2 and FeCl3 (Fe
2+/Fe3+ = ½)
mixed at 90°C were dropped into the solution. The 5 M
NaOH was added dropwise to obtain a pH of 11. The
suspensions were then heated at 90°C for 1h with con-
tinuous agitation (200 rotations/min). The precipitate
was centrifuged and treated repeatedly with HClO4
(3 mol·L−1) solution until the Fe2+/Fe3+ ratio in the
solid was approximately 0.05. After the last separation
by centrifugation, the particles were dispersed into
dextran (20 g in 100 mL of water). The product was
separated by centrifugation (10,000 rpm) and dried at
40°C (sucrose-coated iron oxide (SIO)-NP samples).
In the current experiment, K2Cr2O7 is used as the
titrant to determine the amount of iron. The contents of
Fe2+ and Fe3+ are determined by a common titration
method after dissolution in concentrated hydrochloric
acid. Fe2+ was titrated potentiometrically with K2Cr2O7.
The total Fe content was determined by the same way
after reduction of iron by SnCl2.
Characterization
X-ray diffraction measurements were recorded using a
Bruker D8 Advance diffractometer (Madison, WI, USA),
with Cu Kα radiation, and a high-efficiency one-
dimensional detector (LynxEye type) operated in integra-
tion mode. The diffraction patterns were collected in the
2θ range of 20° to 70°, with a step of 0.02° and a 34-s
measuring time per step. TEM studies were carried
out using a JEOL 200 CX (Akishima-shi, Japan). The
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specimen for TEM imaging was prepared from the
particle suspension in deionized water. A drop of well-
dispersed supernatant was placed on a carbon-coated
200-mesh copper grid, followed by drying the sample at
ambient conditions before it was attached to the sample
holder on the microscope. The magnetic properties
of the samples were measured using a superconduct-
ing quantum interference device (MPMS magneto-
meter, Quantum Design, San Diego, CA, USA) at room
temperature.
The in vitro antibacterial activity
Assessment of the antimicrobial and anti-pathogenic
activity of the new oxides
The in vitro qualitative screening of the antimicrobial ac-
tivity was carried out by an adapted agar diffusion tech-
nique using a bacterial suspension of 0.5 McFarland
density obtained from 24-h cultures. The antimicrobial ac-
tivities of the newly synthesized compounds were
determined against clinical and American Type Culture
Collection (ATCC) reference microbial strains, i.e., P.
aeruginosa 1397, E. faecalis ATCC 29212, C. krusei
963, and E. coli ATCC 25922.
The microbial strain identification was confirmed
using the VITEK 2 automatic system (bioMérieux, Inc.,
Durham, NC, USA). VITEK cards for identification and
susceptibility testing (GNS-522) were inoculated and
incubated according to the manufacturer's recommenda-
tions. The results were interpreted using the software
version AMS R09.1. The compounds were solubilized in
dimethyl sulfoxide to a final concentration of 10 mg/mL.
A volume of 10 μL of each tested compound solution
was distributed directly on the solid medium previously
seeded with the microbial inocula. The inoculated plates
were incubated for 24 h at 37°C. Antimicrobial activity
was assessed by measuring the growth inhibition zone
diameters expressed in millimeters [25-27]. Following
the results of the qualitative screening, only the micro-
bial strains which proved to be susceptible have been
further tested in the quantitative assay.
The quantitative assay of the minimal inhibitory con-
centration (MIC; μg/mL) was based on liquid medium
twofold microdilutions performed in 96-multi-well
plates. For this purpose, serial binary dilutions of the
tested compounds (ranging between 0.01 and 5 μg/mL)
were performed in a 200-μL volume of nutrient broth/
YPG, and each well was seeded with 20 μL of micro-
bial inocula of 0.5 McFarland density. The plates were
incubated for 24 h at 37°C for bacterial strains and for
48 h at 28°C for fungal strains, and MICs were macro-
scopically read as the last concentration of the com-
pound which inhibited microbial growth and by
measuring the absorbance of the obtained culture at
620 nm [25-27].
Results and discussion
The diffraction pattern of DIO-NPs and SIO-NPs
(Figure 1) shows the peaks that correspond to an fcc
maghemite structure (ICSD card no. 01-083-0112) charac-
terized by diffraction planes (220), (311), (400), (422),
(511), and (440). No additional diffraction peaks of any
impurity were detected, demonstrating the high purity of
the synthesized samples. The average particle size was
deduced from the full width at half maximum of six lines
using Scherrer's relation [28,29]:
D ¼
kλ
β cosθ
β ¼ B2jb2
 1
2
where D is the averaged length of coherence domains
(which is of perfectly ordered crystalline domains) taken
in the direction normal to the lattice plane that corre-
sponds to the diffraction line taken into account, β is the
line broadening due to the small crystallite size, λ is the
wavelength of X-rays (1.5406 Å), θ is the Bragg angle, B is
the linewidth, and b is the instrument line broadening. For
linewidths measured as the full width at half maximum
peak intensity, K is 0.89 [30]. The experimental linewidth
was deduced assuming Gaussian profiles for experimental
and instrumental broadening in accord with [31]. The line
broadening is essentially due to the size effect. The aver-
age size, deduced from the full width at half maximum,
has a value of 5.8 (±0.5) nm for DIO-NPs and 7.3 (±0.5)
nm for SIO-NPs. They are consistent with the mean sizes
deduced from high-resolution (HR)-TEM observations
(Figure 2). From the d value of the peaks, the estimated
lattice parameter is 0.835 nm for both samples (DIO-NPs
Figure 1 X-ray diffraction pattern of synthesized DIO-NPs and
SIO-NPs.
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Figure 2 (See legend on next page.)
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and SIO-NPs), which is consistent with the literature
value [32].
The DIO-NPs and SIO-NPs synthesized by the copre-
cipitation method is shown in Figure 2A,B. The synthe-
sized DIO-NPs and SIO-NPs showed well-shaped
spherical nanostructure morphology. Grain size distribu-
tion was determined by measuring the mean diameter,
D, of approximately 500 particles on the micrographs.
These monodisperse nanoparticles have an average grain
size of 6 nm (DIO-NPs) and 8 nm (SIO-NPs). The grain
size distribution was shown in Figure 2E,F. In Figure 2C,
D, we show a HR-TEM picture. The clear lattice fringe
in the HR-TEM image demonstrates the well crystalline
nature of resultant nanoparticles. The interplanar dis-
tances (for DIO-NPs) of 2.51, 2.08, and 1.60 Å were
attributed to the (311), (400), and (511) planes of maghe-
mite, respectively. In the SIO-NP sample, the interplanar
distances of 2.51 and 2.08 Å were consistent with the
(311) and (400) planes of maghemite. Therefore, both X-
ray diffraction patterns and HR-TEM give feature char-
acteristics of the maghemite structure.
Figure 3 shows magnetization as a function of the ap-
plied magnetic field when the magnetization is normal-
ized by the weight of the maghemite nanoparticles. No
significant difference was seen among samples both in
their superparamagnetic and frozen states. The satur-
ation magnetization (MS) at 5 K was approximately 22
emu/g for DIO-NPs and 26 emu/g for SIO-NPs. A de-
creasing size of particles leads to a decrease of MS due
to increased dispersion in the internal exchange [33].
The surface spin disorder, arising from reduced coordin-
ation and broken exchange bonds between surface spins,
is expected to give reduced magnetization for samples
with smaller diameter.
The antibacterial activity of the samples (DIO-NPs and
SIO-NPs) was observed using common bacterial patho-
gens, E. coli, P. aeruginosa (Gram-negative), E. faecalis
(Gram-positive), and a species of fungus (C. krusei). The
antibacterial effect of DIO-NPs on the Gram-negative
bacteria E. coli ATCC 25922 was less visible than that on
the Gram-positive bacteria E. faecalis ATCC 29212 and
C. krusei 963 (a species of fungus) for all concentrations.
DIO-NPs showed highly significant toxicity to all three
bacterial species (Figure 4). The Gram-negative bacteria
P. aeruginosa 1397 is not inhibited in the presence of
DIO-NPs.
Concerning the effect of DIO-NPs on the microbial
growth of the tested strains, we could observe that dif-
ferent concentrations of the tested compound either
inhibited or stimulated the growth of E. faecalis ATCC
29212, E. coli ATCC 25922, and C. krusei 963 strains in
the suspension. At concentrations lower than 2.5 mg/
mL, the DIO-NPs inhibit the growth of the E. coli ATCC
25922 strain. The growth of E. faecalis ATCC 29212 was
inhibited at low concentrations of DIO-NPs (from 0.01
to 1.25 mg/mL). The C. krusei 963 strain is inhibited at
concentrations between 0.01 and 0.625 mg/mL. The
antibacterial activity of DIO-NPS on the Gram-negative
bacteria E. coli ATCC 2912 was higher than that on the
Gram-positive bacteria E. faecalis ATCC29212. This is
in accord to the previous result using PEGylated ZnO
nanoparticles, which exhibited a much stronger antibac-
terial effect on Gram-negative bacteria [34]. On the
other hand, in our study, the SIO-NPs proved to stimu-
late the growth of microbial cells, as demonstrated by
the absorbance measurements at 620 nm of the obtained
cultures (Figure 5).
The intensity of the stimulatory effect on the microbial
growth proved to be proportional with the concentration
of SIO-NPs, as proved by the linear trend lines. In ex-
change, all tested concentrations of DIO-NPs and SIO-
NPs slightly stimulated the growth of P. aeruginosa
1397. In general, the stimulatory effect on the microbial
growth was higher for sucrose than for dextran. These
results may be due to the fact that natural sucrose has a
vital role as a transport carbohydrate and sometimes also
(See figure on previous page.)
Figure 2 Large-area TEM and HR-TEM images and size distributions of DIO-NPs and SIO-NPs. Large-area TEM images of synthesized (A)
DIO-NPs and (B) SIO-NPs. HR-TEM images of (C) DIO-NPs and (D) SIO-NPs. Size distribution of (E) DIO-NPs and (F) SIO-NPs.
Figure 3 Hysteresis loops measured at 5 K for DIO-NP and
SIO-NP samples.
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as a storage carbohydrate. Wu and Birch [35] showed
that some microbes convert sucrose with remarkable
yields into the structural isomers isomaltulose and treha-
lulose, possibly to sequester the sugar in a form that
confers an advantage against competing species. On the
other hand, the use of sucrose isomers is currently lim-
ited by the expense of microbial or enzymatic conversion
from more abundant plant-derived sucrose [36]. The last
studies demonstrated that sucrose content of pulp from
the roots decreased when the number of bacteria
increased under anaerobic storage. A difference in the
antimicrobial activity of DIO-NPs and SIO-NPs may
come from active oxygen species generated by the pow-
der in solution. Indeed, every bacterium responds un-
evenly to oxidative stress due to differences in the
permeability of cell membranes [37]. Some microbial
strains succumb to damage to cell walls by O2− and
others, while others show greater sensitivity to H2O2, as
is the case for E. coli [38]. Shi et al. [39] showed that the
increase of antibacterial activity is directly related to the
increase of active oxygen generated on the surface of
particles of oxide nanoparticle, reducing the size of the
particle. Moreover, the nanoparticle of oxides in solution
enhances the possibility of interaction between the par-
ticle and the bacterial cell due to its surface charge and
surface energy [38,40].
Finally, it is important to emphasize that the antimicro-
bial activity of the DIO-NPs was more potent than that of
the SIO-NPs. NP bacterial interactions are influenced by
interfacial forces, especially electrostatic, that can control
the interaction between NPs and the bacterial surface
[41]. The results showed that antibacterial DIO-NPs were
Figure 4 Antibacterial activity of DIO-NPs using E. coli, E. faecalis, C. krusei, and P. aeruginosa.
Figure 5 Antibacterial activity of SIO-NPs using E. coli, E. faecalis, C. krusei, and P. aeruginosa.
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performed by attaching dextran to iron oxide using a
coprecipitation method. Importantly, the antibacterial ac-
tivities are due to the surfactant from the surface of the
iron oxide nanoparticles. The hydroxyl groups present in
dextran offer many sites for derivatization, and these func-
tionalized glycoconjugates represent a largely unexplored
class of biocompatible and environmentally safe com-
pounds. Therefore, it could be concluded that dextran-
coated iron oxide nanoparticles could be released through
aqueous carbohydrate solutions owing to the stable dis-
persion at molecular level and the slow diffusion from the
stabilizing medium [42]. The mechanism of iron oxide NP
antibacterial activity and the properties related to toxicity
are still not clearly understood.
Conclusions
The polysaccharide-coated maghemite prepared under
simple adapted chemical method has a particle size con-
siderably smaller than that reported in the literature.
The synthesized DIO-NPs and SIO-NPs containing only
maghemite in crystalline phase showed spherical well-
shaped nanostructure morphology. The MS at 5 K of
DIO-NPs and SIO-NPs was approximately 22 emu/g for
DIO-NPs and 26 emu/g for SIO-NPs.
In the current paper, we also showed that yeast
P. aeruginosa 1397 was resistant to DIO-NPs and SIO-
NPs. Antimicrobial activity of the DIO-NPs and SIO-NPs is
influenced by the polysaccharide type and the size of the
particles. The bacterial sensitivity to each type of NP also
varied with the bacterial strain. The antibacterial activity of
PMC-NPs based on dextran was significantly higher than
that of PMC-NPs based on sucrose for E. faecalis ATCC
29212, C. krusei 963, and E. coli ATCC 25922.
Further work is needed to study the effect of antibac-
terial activity of iron oxide nanoparticles with different
sizes and coated with different biopolymers. The present
investigation would therefore facilitate future antibacter-
ial studies on iron oxide nanoparticles and prove to be
an important step in the exploration of nanoparticles for
other microbial processes in commercial utility.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DP conceived the study. SLI and AMP performed the synthesis of the
samples. Characterization of materials was carried out by DP, SLI, AMP, MM,
and SS. SLI performed the antibacterial investigations. MM and SS performed
the magnetic investigations. DP directed the study and wrote the draft
paper. All authors contributed to the interpretation of results and discussion
and have corrected, read, and approved the final manuscript.
Acknowledgements
This work was financially supported by the IFA-CEA program under project
no. C206. The authors would like to thank Professor Carmen Chifiriuc of the
Microbiology Immunology Department, Faculty of Biology, University of
Bucharest, for the assistance with antimicrobial tests and for the constructive
discussions.
Author details
1National Institute of Materials Physics, 105 bis Atomistilor, P.O. Box MG 07,
Bucharest-Magurele 077125, Romania. 2Carol Davila University of Medicine
and Pharmacy, 8 Eroii Sanitari, sector 5, Bucharest, Romania. 3Emergency
Hospital Floreasca, Bucharest 5, Calea Floresca nr 8, sector 1, Bucharest,
Romania. 4ISTO, Université d’Orléans, Orléans cedex 02 45067, France.
Received: 2 September 2012 Accepted: 10 October 2012
Published: 22 October 2012
References
1. Poizot P, Laruelle S, Grugeon S, Dupont L, Tarascon JM: Nano-sized
transition metal oxides as negative-electrode materials for lithium-ion
batteries. Nature 2000, 407:496–499.
2. Karaoğlu E, Kavas H, Baykal A, Toprak MS, Sözeri H: Effect of hydrolyzing
agents on the properties of poly (ethylene glycol)-Fe3O4
nanocomposite. Nano-Micro Lett 2011, 3(2):79–85.
3. Ghoshal S, Ansar AAM, Raja SO, Jana A, Bandyopadhyay NR, Dasgupta AK,
Ray M: Superparamagnetic iron oxide nanoparticle attachment on array
of micro test tubes and microbeakers formed on p-type silicon substrate
for biosensor applications. Nanoscale Res Lett 2011, 6:540.
4. Yu-Hong W, Rui C, Ding L: A quantum dots and superparamagnetic
nanoparticle-based method for the detection of HPV DNA. Nanoscale Res
Lett 2011, 6:461.
5. Piñeiro-Redondo Y, Bañobre-López M, Pardiñas-Blanco I, Goya G,
López-Quintela MA, Rivas J: The influence of colloidal parameters on the
specific power absorption of PAA-coated magnetite nanoparticles.
Nanoscale Res Lett 2011, 6:383.
6. Mahmoudi M, Sant S, Wang B, LaurenSt, Sen T: Superparamagnetic iron
oxide nanoparticles (SPIONs): development, surface modification and
applications in chemotherapy. Adv Drug Deliv Rev 2011, 63:24–46.
7. Karaoğlu E, Deligöz H, Sözeri H, Baykal A, Toprak MS: Hydrothermal
synthesis and characterization of PEG-Mn3O4 nanocomposite. Nano-Micro
Lett 2011, 3(1):25–33.
8. Babes L, Denizot B, Tanguy G, Le Jeune JJ, Jallet P: Synthesis of iron oxide
nanoparticles used as MRI contrast agents: a paramagnetic study. J Coll
Int Sci 1999, 212:474–482.
9. Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA: A synthetic
macromolecule as MRI detectable drug carriers: aminodextran-coated
iron oxide nanoparticles. Carbohyd Polym 2010, 80:695–698.
10. Salgueirino-Maceira V, Correa-Duarte MA: Increasing the complexity of
magnetic core/shell structured nanocomposites for biological
applications. Adv Mater 2007, 19:4131–4144.
11. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M: Recent advances on surface
engineering of magnetic iron oxide nanoparticles and their biomedical
applications. Nanomedicine 2007, 2:23–39.
12. Hou C-H, Hou S-M, Hsueh Y-S, Lin J, Wu H-C, Lin F-H: The in vivo
performance of biomagnetic hydroxyapatite nanoparticles in cancer
hyperthermia therapy. Biomaterials 2009, 30:3956–3960.
13. Predoi D, Kuncser V, Zaharescu M, Keune W, Sahoo B, Valeanu M, Crisan M,
Raileanu M, Jitianu A, Filoti G: Structural and magnetic properties of iron
species/SiO2nanocomposites obtained by sol–gel methods. Phy Status
Solidi C: Conferences 2004, 1(12):3507–3510.
14. Kang YS, Risbud S, Rabolt JF, Stroeve P: Synthesis and characterization of
nanometer-size Fe3O4 and g-Fe2O3 particles. Chem Mater 1996,
8:2209–2211.
15. Predoi D, Kuncser V, Filoti G: Magnetic behaviour of maghemite
nanoparticles studied by Mössbauer spectroscopy. Rom Rep Phys 2004,
56(3):373–378.
16. Jitianu A, Raileanu M, Crisan M, Predoi D, Jitianu M, Stanciu L, Zaharescu M:
Fe3O4-SiO2 nanocomposites obtained via alkoxide and colloidal route.
J Sol–Gel Sci Tech 2006, 40(2–3):317–323.
17. Predoi D, Crisan O, Jitianu A, Valsangiacom MC, Raileanu M, Zaharescu M:
Iron oxide in a silica matrix prepared by the sol–gel method. Thin Solid
Films 2007, 515(16):6319–6323.
18. Guo S, Li D, Zhang L, Li J, Wang E: Monodisperse mesoporous
superparamagnetic single-crystal magnetite nanoparticles for drug
delivery. Biomaterials 2009, 30:1881–1889.
19. Sawai J: Quantitative evaluation of antibacterial activities of metallic
oxide powders (ZnO, MgO and CaO) by conductimetric assay. J Microbiol
Methods 2003, 54:177–182.
Iconaru et al. Nanoscale Research Letters 2012, 7:576 Page 7 of 8
http://www.nanoscalereslett.com/content/7/1/576
20. Limban C, Marutescu L, Chifiriuc MC: Synthesis, spectroscopic properties
and antipathogenic activity of new thiourea. Derivatives Molecules 2011,
16(9):7593–7607.
21. Kim JS, Kuk E, Yu KN, Kim J-H, Park SJ, Lee HJ, Kim SH, Park YK, Hwang C-Y,
Kim YK, Lee YS, Jeong DH, Cho MH: Antimicrobial effects of silver
nanoparticles. Nanomed-Nanotechnol 2007, 3:95–101.
22. Donlan RM, Costerton JW: Biofilms: survival mechanisms of clinically
relevant microorganisms. Clinical Microbiol Rev 2002, 15:167–193.
23. Lazar V, Chifiriuc C: Medical significance and new therapeutical strategies
for biofilm associated infections. Rom Arch Microb & Immunol 2010,
69:125–138.
24. Horst AK: Antimicrobial effects of metal oxide nanoparticles. In The 2009
Research Accomplishments. Ithaca: NNIN; 2009:12–13.
25. Limban C, Chifiriuc MC: Antibacterial activity of new dibenzoxepinone
oximes with fluorine and trifluoromethyl group substituents. Int J Mol Sci
2011, 12(10):6432–6444.
26. Chifiriuc MC, Stecoza C, Dracea O, Larion C, Israil AM: Antimicrobial
activity of some new O-acyloximino-dibenzo[b, e]thiepins and
O-acyloximino-dibenzo[b, e]thiepin-5,5-dioxides against planktonic
cells. RBL 2010, 15(2):5134–5139.
27. Marutescu L, Limban C, Chifiriuc MC, Missir AV, Chirita IC, Caproiu MT:
Studies on the antimicrobial activity of new compounds containing
thiourea function. Biointerface Res Appl Chem 2011, 1(6):236–241.
28. Battaut E: Particle sizes and their statistics from Debye-Sherrer lines. In
International Tables for X-Ray Crystallography. 3rd edition. Edited by
MacGillavary CH, Riecks GD. Boston: D. Reidel; 1962:318–323.
29. Guinier A: X-Ray Diffraction in Crystals, Imperfect Crystals and Amorphous
Bodies. San Francisco: Free-man; 1963.
30. Lamaitre JL, Menon PG, Delannay F: The measurement of catalyst
dispersion. In Characterization of Heterogeneous Catalysts. Edited by
Dellannay F. New York: Marcel Dekker; 1984:325–327.
31. Chaneac C, Tronc E, Jolivet JP: Thermal behavior of spinel iron oxide-silica
composites. Nanostructured Materials 1995, 6(5):715–718.
32. Haynes WM: CRC Handbook of Chemistry and Physics. Boca Raton: CRC; 2012.
33. Elliott SR: Physics of Amorphous Materials. London: Longman; 1984.
34. Nair S, Sasidharan A, Rani VVD, Menon D, Nair S, Manzoor K, Raina S: Role of
size scale of ZnO nanoparticles and microparticles on toxicity toward
bacteria and osteoblast cancer cells. J Mater Sci Mater Med 2009,
20:S235–S241.
35. Wu L, Birch RG: Characterization of the highly efficient sucrose isomerase
from Pantoea dispersa UQ68J and cloning of the sucrose isomerase
gene. Appl Environ Microbiol 2005, 71:1581–1590.
36. Schiweck H, Munir M, Rapp KM, Schneider B, Vogel M: New developments
in the use of sucrose as an industrial bulk chemical. In Carbohydrates as
Organic Raw Materials. Edited by Lichtenthaler FW. Weinheim:
Wiley; 1991:57–94.
37. Elia G, Baladi S, Jacquier-Sarlin MR, Christie P, Perin-Minisini MJ,
Dinh-Xuan AT, Polla BS: Reactive oxygen species as mediators of the
induction of heat shock proteins by environmental stresses: a protective
response. Saishin Igaku 1994, 49:2105–2115.
38. Zhang L, Jiang Y, Ding Y, Povey M, York D: Investigation into the
antibacterial behaviour of suspensions of ZnO nanoparticles
(ZnO nanofluids). J Nanopart Res 2007, 93:479–489.
39. Shi L-E, Xing L, Hou B, Ge H, Guo X, Tang Z: Inorganic nano mental oxides
used as anti-microorganism agents for pathogen control. In Current
Research, Technology and Education Topics in Applied Microbiology and
Microbial. Edited by Mendez-Vilas A. Badajoz: Formatex;
2010:361–368.
40. Yamamoto O: Influence of particle size on the antibacterial activity of
zinc oxide. Int Journal Inorg Mater 2001, 3:643–646.
41. Neal AL: What can be inferred from bacterium-nanoparticle interactions
about the potential consequences of environmental exposure to
nanoparticles? Ecotoxicology 2008, 17:362–371.
42. Saeed R-Z, Saber I, Alimohammad Z, Mojtaba S, Zahra Z: Study of
bactericidal properties of carbohydrate-stabilized platinum oxide
nanoparticles. Int Nano Lett 2012, 2:21.
doi:10.1186/1556-276X-7-576
Cite this article as: Iconaru et al.: Synthesis and characterization of
polysaccharide-maghemite composite nanoparticles and their
antibacterial properties. Nanoscale Research Letters 2012 7:576.
Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Iconaru et al. Nanoscale Research Letters 2012, 7:576 Page 8 of 8
http://www.nanoscalereslett.com/content/7/1/576
